BY: LUCIEN BRUGGEMAN, ABC News(WASHINGTON) -- As the U.S. approaches 200,000 coronavirus deaths, a coalition of 11 state treasurers is calling on drugmaker Gilead Sciences to reduce the price of remdesivir, its promising treatment for some patients of COVID-19.
Latest Local News
North Sound Covid-19 Vaccine Update and More
With the Covid-19 vaccine being deployed in more and ...
More Snow This Weekend – Warmup Next Week
Southern parts of the North Sound, primarily in Snohomish ...